日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention

在临床前模型和人类受试者中,血液中的 Aβ42 在最早的病理前阶段增加,然后随着淀粉样蛋白病理的进行而减少:为预防开辟了新途径

Pablo Botella Lucena #, Sarah Vanherle #, Chritica Lodder #, Manuel Gutiérrez de Ravé, Ilie-Cosmin Stancu, Ivo Lambrichts, Riet Vangheluwe, Rose Bruffaerts, Ilse Dewachter

Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis

比较基于 ELISA 和 SIMOA 的血浆 Aβ 比率量化方法对脑淀粉样变性的早期检测

Steffi De Meyer, Jolien M Schaeverbeke, Inge M W Verberk, Benjamin Gille, Maxim De Schaepdryver, Emma S Luckett, Silvy Gabel, Rose Bruffaerts, Kimberley Mauroo, Elisabeth H Thijssen, Erik Stoops, Hugo M Vanderstichele, Charlotte E Teunissen, Rik Vandenberghe, Koen Poesen